Protein Supplementation and Resistance Training to Prevent Fat-Free Mass Loss Following Metabolic-Bariatric Surgery
NCT ID: NCT07156552
Last Updated: 2025-09-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
400 participants
INTERVENTIONAL
2025-06-20
2027-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants in group 1 will receive standard postoperative care as currently provided. Participants in group 2 will also receive standard care, but in addition, they will be asked to consume extra protein daily and take part in a supervised resistance training session once a week.
Previous research has shown that approximately one in five patients undergoing bariatric surgery experiences excessive muscle loss after the surgery. It is known that resistance training and protein intake can help maintain and even improve muscle mass. However, limited research has been conducted on the combined effects of protein supplementation and resistance training in patients after bariatric surgery. Therefore, the aim of this trial is to determine whether participants receiving the additional intervention experience less muscle mass loss compared to those receiving standard care alone.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nutritional Stimulation of Muscle Protein Synthesis and Metabolic Rate After Bariatric Surgery
NCT04751916
Utilizing Protein During Weight Loss to Impact Physical Function
NCT03074643
Protein Dosing Strategies in Critically Ill Patients: Comparing Actual Body Weight and Fat-Free Mass Approaches in an Observational Cohort Study
NCT07312708
Distinct Sources of Supplementary Protein in the Resistance Exercise Training-induced Adaptations
NCT05710614
Effects of WB-EMS and Protein Supplementation on LBM Maintenance During Intended Weight Loss
NCT03746977
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group - Standard care
No interventions assigned to this group
Intervention group - Enriched care
Resistance exercise training and protein supplementation
The intervention consists of two components:
1. Resistance Exercise Training Participants will engage in a 24-week resistance training program. This program includes one supervised session per week supervised by a qualified kinesiologist, complemented by two to three additional unsupervised sessions per week performed at home.
2. Protein Supplementation
Participants will receive daily protein supplements for a total duration of 12 weeks. The dosage will be progressively increased:
* 20 grams per day during weeks 1-4
* 40 grams per day during weeks 5-8
* 60 grams per day during weeks 9-12 After the 12-week supplementation period, participants will receive additional dietary counseling sessions with a dietitian. These sessions aim to support the maintenance of adequate protein intake through dietary intake.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Resistance exercise training and protein supplementation
The intervention consists of two components:
1. Resistance Exercise Training Participants will engage in a 24-week resistance training program. This program includes one supervised session per week supervised by a qualified kinesiologist, complemented by two to three additional unsupervised sessions per week performed at home.
2. Protein Supplementation
Participants will receive daily protein supplements for a total duration of 12 weeks. The dosage will be progressively increased:
* 20 grams per day during weeks 1-4
* 40 grams per day during weeks 5-8
* 60 grams per day during weeks 9-12 After the 12-week supplementation period, participants will receive additional dietary counseling sessions with a dietitian. These sessions aim to support the maintenance of adequate protein intake through dietary intake.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participation in the NOK care program
* Able to understand and perform the study procedures
Exclusion Criteria
* Diagnosed renal insufficiency
* Diagnosed intestinal diseases influencing the uptake of protein (i.e. active inflammatory bowel disease
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)
OTHER
ZonMw: The Netherlands Organisation for Health Research and Development
OTHER
Nederlandse Obesitas Kliniek
UNKNOWN
Radboud University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
M. T.E. Hopman, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
Radboud University Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nederlandse Obesitas Kliniek
Amsterdam, , Netherlands
Nederlandse Obesitas Kliniek
Nieuwegein, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL87367.091.24
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.